Pro 2014-024 (Announcement of Resolution of 19th Session of 8th Board of Directors of Jianfeng Group)
Release time:
2020-08-05
Securities Code: 600668 Securities Short Name: Jianfeng Group No.: Pro 2014-024
Bond Short Name: 13 Peak 01 Bond Code: 122227
Zhejiang Jianfeng Group Co., Ltd.
The 19th Board of Directors Resolution Announcement
The board of directors and all directors of the company guarantee that the content of this announcement does not contain any False records, misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents .
On October 27, 2014, Zhejiang Jianfeng Group Co., Ltd. held the 19th meeting of the eighth board of directors by means of correspondence. The company currently has eight directors. The eight directors who participated in the voting complied with the relevant provisions of the "Company Law" and the company's "Articles of Association". The resolutions made were legal and valid. The following resolutions were passed by vote:
1. "Company's Third Quarter Report 2014"
After deliberation and voting, the board of directors passed "Company's Third Quarter Report 2014"
voting results: 8 votes in favor, 0 votes against and 0 abstentions. The full text of the third quarter report of
company in 2014 can be found on the website of Shanghai Stock Exchange.
2. the "Proposal on Changes in the Company's Accounting Policy"
After deliberation and voting, the board of directors passed the "Proposal on Changes in the Company's Accounting Policy"
Voting result: 8 votes in favor, 0 votes against and 0 abstentions. For details, please refer to the Company's Announcement on Changes in the Company's Accounting Policy (P.2014 -027).
3. "Proposal on the expiration of the term of office of the board of directors"
After deliberation and voting, the board of directors passed the "Proposal on the expiration of the term of office of the board of directors"
voting result: 8 votes in favor, 0 votes against and 0 abstentions.
According to the company's "Articles of Association", the term of office of the board of directors is three years, and the term of office of the current board of directors will be renewed. The company's largest shareholder, Jinhua Tongji State-owned Assets Investment Company, recommended Mr. Jiang Xiaomeng, Mr. Yu Jianhong, Mr. Wu Guanghui, and Mr. Zhu Linming as candidates for the company's ninth board of directors. The current board of directors recommends: Mr. Du Zihong, Mr. Huang Sujian, Mr. Zhang Yuyou, Mr. Wu Xiaoming, and Mr. Shi Ximin are candidates for the ninth board of directors of the company, of which Mr. Zhang Yuyou, Mr. Wu Xiaoming, and Mr. Shi Ximin are independent director candidates;
More than 9 candidates will be submitted to the general meeting of shareholders as candidates for the ninth board of directors of the company.
The three independent directors of the company expressed their independent opinions on this and agreed to the proposal on the change of the board of directors passed at the meeting. At the same time, they believed that the formation of the above resolutions complied with the relevant provisions of the Company Law and the Company's Articles of Association, and did not harm the small and medium shareholders. Interests.
4. "Proposal on Convening the First Extraordinary General Meeting of Shareholders in 2014"
After deliberation and voting, the board of directors passed the proposal, and the company will hold the first extraordinary general meeting of shareholders in 2014 on November 12, 2014.
Voting result: 8 votes in favor, 0 votes against, 0 abstentions.
For details, please refer to the Company's Notice on Convening the First Extraordinary General Meeting of Shareholders in 2014 (P.2014 -026).
hereby announces
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
October 27, 2014
Attached: Resumes of Director Candidates
1
,Mr. Jiang Xiaomeng : 1964 11 Born, master of Business Administration / Engineering, professor-level senior engineer, licensed pharmacist, expert enjoying special allowance from the State Council, young and middle-aged expert with outstanding contribution from Zhejiang Province, 1980 , 12 , joined the work, successively served as workshop director of Jinhua Cement Plant, manager of the company's enterprise management department, general manager of Zhejiang Jianfeng Communication Cable Co., Ltd., general manager of Zhejiang Jianfeng Pharmaceutical Co., Ltd, deputy General Manager and General Manager of the Company. He is currently chairman and secretary of the party Committee of of the company, concurrently serving: vice Chairman of Tianshili Holding Group Co., Ltd. , Vice Chairman of Tianshili Pharmaceutical Group Co., Ltd., Director of Southern Cement Co., Ltd., Chairman of Zhejiang Jinhua Southern Peak Cement Co., Ltd. , Director of Jinhua Tongji State-owned Assets Investment Co., Ltd., Vice Chairman of Zhejiang Entrepreneurs Association, Vice Chairman of Zhejiang Pharmaceutical Industry Association, Zhejiang Building Materials Industry Association vice President, President of Jinhua Entrepreneurs Association, Vice President of Jinhua General Chamber of Commerce. 2
,Du Zihong : 1939 12 March, senior economist, 1957 12 July to work, 1983 as director of Jinhua Cement Factory, and later served as general manager, chairman and party secretary of the company, the current director of the company , concurrently: Tianshili Holdings Group Co., Ltd. director, vice president of China Enterprise Management Research Association. 3
,Mr. Yu Jianhong : 1966 10 June born, senior economist , engineer , 1987 9 February joined the work, successively served as deputy director of Jinhua cement factory machine repair workshop, technical section chief, deputy director and director of Jinsong cement factory, general Manager of Jianfeng Group Jinhua Jinma Cement Co., Ltd., General Manager of Zhejiang Jianfeng Cement Co., Ltd. , Deputy General Manager of the Company, currently Director and General Manager of the Company, concurrently Vice President of Zhejiang Cement Association. 4
,Mr. Huang Sujian : 1955 11 July, doctor of economics, researcher, 1978 - 1985 studied in the Department of Economics of Xiamen University and obtained bachelor's and master's degrees successively, graduated from the Department of Industrial Economics of the Graduate School of the Chinese Academy of Social Sciences in 1988 with a doctorate. He is currently the deputy director of the Institute of Industrial Economics of the Chinese Academy of Social Sciences and a director of the company. Part-time: Professor of Graduate School of Chinese Academy of Social Sciences, Director of Management Science and Innovation Development Research Center of Chinese Academy of Social Sciences, Deputy Editor of "Economic Management " Magazine, Chairman of China Enterprise Management Research Association, Zhejiang China Commodity City Independent director of Group Co., Ltd., independent director of Shenzhen Yingshisheng Information Technology Co., Ltd., independent director of Wolong Real Estate Group Co., Ltd. 5
, Mr. Wu Guanghui:1965 August May students, postgraduate degree, 1988 August to work. He once served as deputy secretary and head of Sumeng Township Party Committee of Wucheng District, Jinhua City, 202, director of Jinhua Economic and Technological Development Zone Construction Planning Bureau, director of Jinhua Economic and Technological Development Zone Branch of Jinhua City Planning Bureau, chief engineer of Jinhua City Construction Bureau, deputy head of Wuyi County of 208 Jinhua City, deputy secretary of Party Working Committee and deputy director of Administrative Committee of and Secretary of Sumeng Township Party Committee. is currently the chairman of of Jinhua Transportation Construction Investment Co., Ltd. 6 , Mr. Zhu Linming : 197 4
7 April, undergraduate , graduated from Zhejiang Institute of Education , 19 93 March, successively served as a member of Jinhua Education Commission, deputy Director and Director of the Organization Department of the CPC Jinhua Municipal Committee, Director of Jinhua Tongji State-owned Assets Investment Co., Ltd. Director . He is currently the general manager of and chairman of of Jinhua State-owned Assets Management Co., Ltd. 7, Zhang Yuyou: Born in December 1946, senior engineer. He joined the work in December 1968 and successively worked in Sichuan Emei Cement Plant and Zhejiang Changxing Cement Plant. He once served as Deputy Secretary of the Party Committee, Deputy General Manager, Secretary of the Party Committee and General Manager of Zhejiang Building Materials Industry Corporation. He is currently an independent director of the Company and concurrently serves as the president of Zhejiang Building Materials Industry Association. 8. Mr. Wu Xiaoming, born in June 1954, is a doctor of pharmacy. He was once a professor, doctoral supervisor and president of China Pharmaceutical University. He is currently a professor and doctoral supervisor of China Pharmaceutical University. He is also the vice president of China Pharmaceutical Association, the executive vice president of China Pharmaceutical Education Association, the chairman of Pharmaceutical Education Research Association, the member of the sixth science and Technology Committee of the Ministry of education, the vice chairman of the national pharmaceutical professional degree graduate education steering committee, the honorary chairman of Jiangsu Pharmaceutical Association, and the chairman of Jiangsu Pharmaceutical Research and Development Association, director of the editorial board of pharmaceutical textbooks of national pharmaceutical colleges, editor-in-chief of "Chinese Natural Medicine" magazine, editor-in-chief of "Pharmaceutical Education" magazine, deputy editor-in-chief of "Chinese Pharmaceutical Yearbook", and editorial board and specially invited editorial board of many national pharmaceutical academic journals.
9, Mr. Shi Ximin, born in June 250, 1960, doctor of management (accounting major), professor of accounting . He joined the work in 1983 and served as a teacher of the Department of Business and Economics of Anhui University of Finance and Trade in 253, deputy dean of the School of Accounting of Zhejiang University of Finance and Economics, director of the Graduate Department, and dean of Zhejiang Vocational and Technical College of Commerce
. He is currently a professor at the School of Accounting of Zhejiang University of Finance and Economics, vice president of Zhejiang Association of Chief Accountants and independent director ofof 255 Wolong Real Estate Group Co., Ltd.
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31